Vigil Neuroscience, Inc.
VIGLDelisted Aug 5, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001827087
Vigil Neuroscience, Inc. was delisted on Aug 5, 2025; its insiders filed their last Form 4 on Aug 7, 2025; 78 institutions reported holding it in 13F filings for Q2 2025, worth $265.8M in total; no superinvestor held it.
Q3 2024 vs. Q2 2024
How the institutions holding Vigil Neuroscience, Inc. changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Of which not filed for Q3 2024 | Q3 2024 | Change |
|---|---|---|---|---|
| Holders | 58 | 1 | 52 | −5 |
| Shares | 26.1M | 405.0K | 27.7M | +2.00M (+7.8%) |
| Value | $104.5M | $1.62M | $94.2M | −$8.67M (−8.4%) |
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (11)
Institutions that held Vigil Neuroscience, Inc. at the end of Q3 2024 but not at the end of Q2 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Siren, L.L.C. | 1,991,038 | $6.77M | 0.34% |
| BlackRock, Inc. | 422,547 | $1.44M | 0.00% |
| Standard Life Aberdeen plc | 235,011 | $799.0K | 0.00% |
| Marshall Wace, LLP | 144,042 | $489.7K | 0.00% |
| Verition Fund Management LLC | 130,030 | $442.1K | 0.00% |
| Sherbrooke Park Advisers LLC | 26,329 | $89.5K | 0.02% |
| ADAR1 Capital Management, LLC | 21,737 | $73.9K | 0.01% |
| Two Sigma Advisers, LP | 20,100 | $68.3K | 0.00% |
| American Century Companies Inc | 19,970 | $67.9K | 0.00% |
| Jump Financial, LLC | 10,000 | $34.0K | 0.00% |
| Gotham Asset Management, LLC | 5,933 | – | – |
Sold out (16)
Institutions that held Vigil Neuroscience, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| Artal Group S.A. | 1,828,691 | $7.31M |
| Goldman Sachs Group Inc | 401,139 | $1.60M |
| Jane Street Group, LLC | 62,354 | $249.4K |
| Susquehanna International Group, LLP | 48,051 | $192.2K |
| Alpine Global Management, LLC | 44,893 | $179.6K |
| Y-Intercept (Hong Kong) Ltd | 38,364 | $153.5K |
| Centiva Capital, LP | 32,800 | $131.2K |
| Paloma Partners Management Co | 16,609 | $66.4K |
| Prelude Capital Management, LLC | 10,867 | $43.5K |
| Mirae Asset Global ETFs Holdings Ltd. | 8,135 | $32.5K |
| Acadian Asset Management LLC | 6,598 | $26.0K |
| Rhumbline Advisers | 2,588 | $10.4K |
| Russell Investments Group, Ltd. | 2,029 | $8.12K |
| Macquarie Group Ltd | 831 | $3.32K |
| New York State Common Retirement Fund | 140 | $560 |
| CWM, LLC | 16 | $0 |
Not filed for Q3 2024 yet (1)
Institutions that held Vigil Neuroscience, Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| BlackRock Inc. | 405,043 | $1.62M |